These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 19133667)
1. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Sievert H; Ruygrok P; Salkeld M; Baumgartner H; Meier B; Windecker S; Juliard JM; Aubry P; Tiefenbacher C; Krumsdorf U; Vermeersch P; Ewert P; Piéchaud JF Catheter Cardiovasc Interv; 2009 Feb; 73(3):368-73. PubMed ID: 19133667 [TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience. Sievert H; Fischer E; Heinisch C; Majunke N; Roemer A; Wunderlich N Circulation; 2007 Oct; 116(15):1701-6. PubMed ID: 17893276 [TBL] [Abstract][Full Text] [Related]
3. Patent foramen ovale percutaneous closure: the no-implant approach. Butera G; Romagnoli E; Sangiorgi G; Caputi L; Chessa M; Carminati M Expert Rev Med Devices; 2008 May; 5(3):317-21. PubMed ID: 18452381 [TBL] [Abstract][Full Text] [Related]
4. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique. Majunke N; Baranowski A; Zimmermann W; Heinisch C; Wilson N; Robertson G; Wunderlich N; Sievert H Catheter Cardiovasc Interv; 2009 Feb; 73(3):376-82. PubMed ID: 19085919 [TBL] [Abstract][Full Text] [Related]
5. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder. Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463 [TBL] [Abstract][Full Text] [Related]
6. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia. Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009 [TBL] [Abstract][Full Text] [Related]
7. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects. Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787 [TBL] [Abstract][Full Text] [Related]
8. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study. Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695 [TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525 [TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism. Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure. Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251 [TBL] [Abstract][Full Text] [Related]
12. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM; Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668 [TBL] [Abstract][Full Text] [Related]
14. Comparison of contemporary devices used for transcatheter patent foramen ovale closure. Spies C; Reissmann U; Timmermanns I; Schräder R J Invasive Cardiol; 2008 Sep; 20(9):442-7. PubMed ID: 18762672 [TBL] [Abstract][Full Text] [Related]
15. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry. Alameddine F; Block PC Catheter Cardiovasc Interv; 2004 Aug; 62(4):512-6. PubMed ID: 15274163 [TBL] [Abstract][Full Text] [Related]
16. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia. Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021 [TBL] [Abstract][Full Text] [Related]
17. Early experience with a simplified technique for transcatheter closure of the patent foramen ovale. Kutty S; Nykanen DG; Zahn EM Heart Lung Circ; 2009 Dec; 18(6):384-7. PubMed ID: 19783211 [TBL] [Abstract][Full Text] [Related]
18. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330 [TBL] [Abstract][Full Text] [Related]
19. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder. Spies C; Strasheim R; Timmermanns I; Schraeder R Eur Heart J; 2006 Feb; 27(3):365-71. PubMed ID: 16254007 [TBL] [Abstract][Full Text] [Related]